Bayer Aktiengesellschaft (BUD:BAYER)
Hungary · Delayed Price · Currency is HUF | Market Cap | 17.08T +58.7% |
| Revenue (ttm) | 17.46T -2.9% |
| Net Income | -832.11B |
| EPS | -847.00 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 10.97 |
| Dividend | 40.15 (0.24%) |
| Ex-Dividend Date | Apr 27, 2026 |
| Volume | 129 |
| Open | 16,450 |
| Previous Close | 16,480 |
| Day's Range | 16,450 - 17,005 |
| 52-Week Range | 10,000 - 18,700 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 4, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Bayer upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Bayer (BAYRY) to Buy from Hold with a price target of EUR 60, up from EUR 45. The firm says last week’s Supreme Court ruling is pivotal…
Bayer fuels break-up talk as Roundup business put into separate unit
Bayer BAYGn.DE said on Thursday it was consolidating its U.S. Roundup business in a new unit, less than a week after scoring a major legal victory that blocked thousands of state-court lawsuits relat...
Bayer Group announces consolidation of U.S. glyphosate business into Ruveon
Bayer (BAYRY) Group announced the consolidation of the U.S. glyphosate business into Ruveon LLC to optimize and align the business with the specific needs of the U.S. market environment. Ruveon…
Bayer removed from European Conviction List at Goldman Sachs
Goldman Sachs analysts removed Bayer (BAYRY) from the firm’s European Conviction List as part of its monthly update.
Bayer seeks US duties on Chinese-made glyphosate, angering farmers
June 30 (Reuters) - Bayer asked Washington to impose duties on glyphosate, the chemical used in the company's weedkiller Roundup, imported from China, saying it was being sold at artificially low pr...
Bayer Gets New Life After Supreme Court's Roundup Ruling
A high-court victory gives the German company more leverage to settle outstanding cases.
Bayer says Durnell Roundup ruling ‘should help significantly contain litigation’
Bayer (BAYRY) stated: “The U.S. Supreme Court issued a 7:2 landmark ruling in the Durnell Roundup case on Thursday, affirming that the Federal Insecticide, Fungicide, and Rodenticide Act expressly pre...
Bayer's stock jumps after Supreme Court sides with Roundup weedkiller manufacturer
The court ruled that states cannot have differing labeling warning rules than federal law requires.
Bayer wins Supreme Court case making it harder to sue over glyphosate in Monsanto's Roundup
The Supreme Court in a 7-2 decision on Thursday said Bayer cannot be sued over state-level claims that the company failed to warn of cancer risks from its weedkiller Roundup and its chemical glyphosat...
Bayer Not Liable After Man Claimed Weedkiller Caused His Cancer, Supreme Court Rules
The Supreme Court ruled in favor of former agrochemical giant Monsanto on Thursday in a dispute over whether the company should have warned consumers about potential harms arising from its weed killer...
Bayer shares surge after U.S. Supreme Court rules in favour of company
Shares in Germany's Bayer surged by the most in 23 years on Thursday after the U.S. Supreme Court sided with the the company concerning lawsuits related its Roundup weedkiller.
Bayer confirms Supreme Court rules in favor of Monsanto in Durnell case
Bayer (BAYRY) issued the following statement: “The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significant...
Bayer Wins Supreme Court Challenge Over Roundup Litigation
The decision will help the company in its bid to resolve thousands of claims that the popular weedkiller caused cancer.
Bayer, Iambic collaborate for AI drug discovery
Bayer (BAYRY) and Iambic Therapeutics announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic’s AI-driven platform. The collaboration is focused on small molec...
Bayer and Iambic Collaborate to Advance Drug Discovery with AI
BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a...
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
CALGARY, Alberta--(BUSINESS WIRE)--The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this ro...
Judge sends Roundup class settlement back to Missouri court, Bloomberg says
A federal judge has remanded the Roundup settlement back to the Missouri State Court, according to Bloomberg’s Alexey Anishchuk, citing an emailed statement from Bayer (BAYRY). Bayer’s U.S. subsidiary...
Federal judge sends Bayer's $7.25 billion Roundup settlement back to Missouri state court
A federal judge on Wednesday returned Bayer's proposed $7.25 billion settlement of Roundup lawsuits to Missouri state court, overruling the objections of some cancer victims who said the state cour...
Bayer Completes Acquisition of Perfuse Therapeutics
BERLIN--(BUSINESS WIRE)--Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced p...
Bayer price target raised to EUR 40.50 from EUR 40 at Berenberg
Berenberg analyst Sebastian Bray raised the firm’s price target on Bayer (BAYRY) to EUR 40.50 from EUR 40 and keeps a Hold rating on the shares.
Bayer announces FDA approval for Ambelvist
Bayer (BAYRY) announced that the FDA approved Ambelvist, a new, intravenous macrocyclic gadolinium-based contrast agent indicated for contrast-enhanced magnetic resonance imaging to detect and visuali...
Bayer's AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) approved AMBELVIST® (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contras...
Bayer hopes to speed up biofuel feedstock plan amid Iran war energy crunch
Bayer is hoping to speed up a plan to facilitate North American production of biofuel feedstocks like camelina in the wake of the Iran war, the drug-making and crop science giant said on Wednesday.
Bayer appoints Reinhard as President of the Radiology business
Bayer (BAYRY) announced that Dr. Jost Reinhard has been appointed President of the Radiology business within Bayer’s Pharmaceuticals Division, effective August 1, 2026. In his new capacity, he will re...
Dr. Jost Reinhard Appointed President of Bayer's Radiology Business
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that Dr. Jost Reinhard has been appointed President of the Radiology business within Bayer's Pharmaceuticals Division, effective August 1, 2026. ...